Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Vanessa Monteil(Karolinska University Hospital), Hyesoo Kwon(Swedish Veterinary Agency), Patricia Prado(Institute for Bioengineering of Catalonia), Astrid Hagelkrüys(Institute of Molecular Biotechnology), Reiner Wimmer(Institute of Molecular Biotechnology), Martin Ståhl(Stemcell Technologies), Alexandra Leopoldi(Institute of Molecular Biotechnology), Elena Garreta(Institute for Bioengineering of Catalonia), Carmen Hurtado del Pozo(Institute for Bioengineering of Catalonia), Felipe Prósper(Universidad de Navarra), Juan P. Romero(Universidad de Navarra), Gerald Wirnsberger(Vienna Biocenter), Haibo Zhang(St. Michael's Hospital), Arthur S. Slutsky(St. Michael's Hospital), Ryan Conder(Stemcell Technologies), Núria Montserrat(Institució Catalana de Recerca i Estudis Avançats), Alì Mirazimi(Swedish Veterinary Agency), Josef Penninger(Institute of Molecular Biotechnology)
Cell
April 24, 2020
Cited by 2,259Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis